-
1
Bevacizumab the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer /
Published 2009Subjects: Get full text
Series
Electronic Video -
2
Bevacizumab the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer /
Published 2009Subjects: Get full text
Series
Electronic Video -
3
Bevacizumab the first FDA-approved angiogenesis inhibitor in the treatment of non-small cell lung cancer /
Published 2009Subjects: Get full text
Series
Electronic Video